Literature DB >> 15123044

Musculoskeletal disorders in secondary amyloidosis and hereditary fevers.

Gilles Grateau1.   

Abstract

Amyloidosis remains a severe potential complication of many chronic inflammatory disorders, foremost of rheumatoid arthritis. It is not exactly known why some patients develop a progressive amyloidosis while others do not, although latent deposits may be present. It is likely that more potent anti-inflammatory drugs recently used in rheumatoid arthritis have led to a decrease of amyloid-associated (AA) amyloidosis. However, overt amyloidosis remains a severe complication of some chronic inflammatory disorders and it has a poor prognosis. Hereditary fevers are a group of diseases characterized by intermittent bouts of clinical inflammation with focal organ involvement, mainly abdomen, musculoskeletal system and skin. The most frequent is familial Mediterranean fever which affects patients of Mediterranean descent all over the world. Three other types have been recently characterized clinically as well as genetically. A thorough diagnosis is warranted, as clinical and therapeutic management is specific for each of these diseases.

Entities:  

Mesh:

Year:  2003        PMID: 15123044     DOI: 10.1016/j.berh.2003.09.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  4 in total

1.  [Amyloid diagnostics in rheumatic diseases].

Authors:  C Röcken; J Ernst
Journal:  Pathologe       Date:  2006-11       Impact factor: 1.011

2.  Renal amyloidosis: an uncommon complication of juvenile idiopathic arthritis.

Authors:  Carolina Duarte; Clara Gomes; A Jorge Correia; Manuel Salgado
Journal:  Clin Rheumatol       Date:  2005-11-01       Impact factor: 2.980

Review 3.  Secondary intestinal amyloidosis presenting intractable hematochezia: a case report and literature review.

Authors:  So Hyun Kim; Jae Hwang Kim; Mi Jin Gu
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

4.  Systemic arthritis in children: a review of clinical presentation and treatment.

Authors:  R Gurion; T J A Lehman; L N Moorthy
Journal:  Int J Inflam       Date:  2011-12-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.